Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
Classifica tra le azioni #25697
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
Prezzo delle azioni
$2.09
Ultima sincronizzazione: 2022-03-21
Capitalizzazione di mercato
$47.04M
Variazione (1 giorno)
-0.48%
Variazione (1 anno)
0.00%
Paese
US
Scambia Recro Pharma, Inc. (REPH)

Categoria

Storico del prezzo dell'azione per Recro Pharma, Inc. (REPH)
Prezzo di chiusura più alto: $1.92 il 2022-03-01

Prezzo di chiusura più basso: $8.10 il 2014-03-01
Storico del prezzo dell'azione di Recro Pharma, Inc. dal 2014 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2022 23.15%
2021 -43.90%
2020 -83.97%
2019 139.49%
2018 -25.26%
2017 33.81%
2016 -16.69%
2015 218.14%
2014 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$163.75 27.60%
DE
$37.64 23.17%
JP
$220.05 30.36%
CH
$21.01 11.83%
IN